Effective cholesterol lowering after myocardial infarction in patients with nephrotic syndrome may require a multi-pharmacological approach: a case report.

Eur Heart J Case Rep · 2021 · PMC8189300 · PMID 34124564

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

might be significantno p-value reported

10 Evolocumab and rituximab are similar in size, which could support the theory that urinary leakage of evolocumab might be significant in nephrotic patients.

also in 2,435 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.